Disruptive technology reduces bleeding in hemophilia by 87 percent
Monday, July 10, 2017 - 11:32
in Health & Medicine
Researchers at Children's Hospital Los Angeles developed a new therapy called emicizumab that decreases bleeding episodes by nearly 90 percent.